Many anti-abortion agencies in Britain say there could a possible surge in abortions after the release of a new DNA testing kit which determines the sex of a baby six weeks into pregnancy.

Manufactured by British company DNA worldwide, The Early Gender Test checks blood from the mother for Y-chromosomes and determines the presence of boy. The test which went on sale on the Internet to non-U.S. customers this week, costs 190 pounds ($375)

Researchers in the United States and Canada have found a genetic link to heart disease. A separate study by researchers in Iceland found that the same genetic factor was linked to about 20 percent of all heart attacks.

U.S. and Canadian researchers found that as many as one in four white people carry the section of DNA that boosts heart attack risk by up to 40 percent

A recent study has identified a tiny molecule in the microRNA of the mice, which aids their immune system thus suggesting that the corresponding human gene will have a similar vital role.

The study, which was published Friday in journal Science, reports that the laboratory mice in which the so-called microRNA molecule was neutralized or "knocked out" showed lower resistance to infection by bacteria such as salmonella

Scientists have achieved a breakthrough in the field of diabetes research by identifying three new genes which will help understand the causes of diabetes.

Scientists from Oxford, Dundee University and Exeter, followed patient data gathered in Tayside and Fife and tested the DNA of more than 32,000 people in five countries to track spots that harbor genetic risk factors for diabetes. The three new genes that have recently been discovered to develop Type 2 diabetes brings the total number of genes involved to nine

The latest news from the American Cancer Society reports three separate published DNA studies may lead to genetic testing to help identify those individuals who are at the highest risk of developing prostate cancer.

Scientists have found common DNA variations that isolate signals of risk carriers for prostate cancer